Diarrhoea, Diarrhea, Dehydration and Oral Rehydration - Rehydration Project home

Diarrhoea Kills a Child Every 26 Seconds
 

Home > Oral Rehydration Salts > Low-osmolarity ORS > A New Reduced Osmolarity Formulation

Oral Rehydration Salts
Low-osmolarity ORS
Oral Rehydration Therapy
Made at Home
Treat Your Child's Diarrhoea at Home
Frequently Asked Questions
Rice-Based ORS
ORS WHO UNICEF Update
The Salts of Life
Rehydration Saves More Children

Low-osmolarity Oral Rehydration Salts
New Formula of Oral Rehydration Salts
Expert Consultation
WHO UNICEF Statement
New Formula will save millions
New Formula Studies
Low-osmolarity ORS Questions & Answers
Frequently Asked Technical Questions
Production of Low-osmolarity Oral Rehydration Salts

Oral Rehydration Therapy
Oral Rehydration Therapy (ORT) History
ORT: Celebration and Challenge
How Oral Rehydration Works
Management of Diarrhoea and use of ORT
Achievements and Challenges
25 Years of Saving Lives
Knowledge and Use of ORT
Communication and Social Mobilization
The Solution is in Your Hands
A Solution for Survival
Brochure: A Pocket Reference for Scouts
ORT: Elixir of life
ORT: Saved My Daughter's Life
ORT: Success Stories

Oral Rehydration Salts ORS)
A New Reduced Osmolarity Formulation

WHO UNICEF


May 10, 2002

ORAL REHYDRATION SALTS (ORS)
A NEW REDUCED OSMOLARITY FORMULATION


For more than 25 years WHO and UNICEF have recommended a single formulation of glucose-based Oral Rehydration Salts (ORS) to prevent or treat dehydration from diarrhoea irrespective of the cause or age group affected. This product, which provides a solution containing 90 mEq/l of sodium with a total osmolarity of 311 mOsm/l, has proven effective and without apparent adverse effects in worldwide use. It has contributed substantially to the dramatic global reduction in mortality from diarrhoeal disease during the period. For the past 20 years, numerous studies have been undertaken to develop an “improved” ORS. The goal was a product that would be at least as safe and effective as standard ORS for preventing or treating dehydration from all types of diarrhoea but which, in addition, would reduce stool output or have other important clinical benefits. One approach has consisted in reducing the osmolarity of ORS solution to avoid possible adverse effects of hypertonicity on net fluid absorption. This was done by reducing the solution’s glucose and salt (NaCl) concentrations . Studies to evaluate this approach were reviewed at a consultative technical meeting held in New York (USA) in July 2001 1, and technical recommendations were made to WHO and UNICEF on the efficacy and safety of reduced osmolarity ORS in children with acute non-cholera diarrhoea, and in adults and children with cholera. These studies showed that the efficacy of ORS solution for treatment of children with acute non-cholera diarrhoea is improved by reducing its sodium concentration to 75 mEq/l, its glucose concentration to 75 mmol/l, and its total osmolarity to 245 mOsm/l. The need for unscheduled supplemental IV therapy in children given this solution was reduced by 33%. In a combined analysis of this study and studies with other reduced osmolarity ORS solutions (osmolarity 210-268 mOsm/l, sodium 50-75 mEq/l) stool output was also reduced by about 20% and the incidence of vomiting by about 30% 1. The 245 mOsm/l solution also appeared to be as safe and at least as effective as standard ORS for use in children with cholera. The reduced osmolarity ORS containing 75 mEq/l sodium, 75 mmol/l glucose (total osmolarity of 245 mOsm/l) is as effective as standard ORS in adults with cholera. However, it is associated with an increased incidence of transient, asymptomatic hyponatraemia. This reduced osmolarity ORS may be used in place of standard ORS for treating adults with cholera, but careful monitoring is advised to better assess the risk, if any, of symptomatic hyponatraemia.Because of the improved effectiveness of reduced osmolarity ORS solution, especially for children with acute, non-cholera diarrhoea, WHO and UNICEF now recommend that countries use and manufacture the following formulation in place of the previously recommended ORS solution with a total osmolarity of 311 mOsm/l.
1 Reduced osmolarity oral rehydration salts (ORS) formulation Report from a meeting of experts jointly organised by UNICEF and WHO. WHO/CAH/01.22

Reduced osmolarity ORS

grams
/litre

Reduced osmolarity ORS

mmol/
litre

Sodium chloride

2.6

Sodium

75

Glucose, anhydrous

13.5

Chloride

65

Potassium chloride

1.5

Glucose, anhydrous

75

Trisodium citrate dihydrate

2.9

Potassium

20

Citrate

10

Total Weight 20.5

Total Osmolarity

245


Although this single ORS formulation is recommended, WHO and UNICEF have previously published criteria, which remain unchanged, for acceptable ORS formulations. These criteria are listed below; they specify the desired characteristics of the solution after it has been prepared according to the instructions on the packet:

The total substance concentration

(including that contributed by glucose)
should be within the range of 200-310 mmol/l


The individual substance concentration

Glucose

should at least equal that of sodium but
should not exceed 111 mmol/l

Sodium

should be within the range of 60-90 mEq/l

Potassium

should be within the range of 15-25 mEq/l

Citrate

should be within the range of 8-12 mmol/l

Chloride

should be within the range of 50-80 mEq/l

updated: 21 April, 2014

Feedback Form